VOLORIDGE INVESTMENT MANAGEMENT, LLC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$819,550
-80.0%
150,930
-54.1%
0.01%
-77.3%
Q3 2022$4,107,000
+1087.0%
328,800
+871.1%
0.02%
+1000.0%
Q4 2021$346,000
-89.3%
33,859
-86.0%
0.00%
-90.5%
Q3 2021$3,247,000
-57.4%
241,953
-30.3%
0.02%
-60.4%
Q2 2021$7,616,000
-7.8%
347,124
+1.1%
0.05%
-11.7%
Q1 2021$8,261,000
+77.5%
343,366
+32.7%
0.06%
+53.8%
Q4 2020$4,655,000
+1978.1%
258,777
+1237.1%
0.04%
+1850.0%
Q3 2020$224,000
+7.2%
19,354
+2.2%
0.00%
-66.7%
Q1 2020$209,000
-50.4%
18,943
-25.3%
0.01%
-53.8%
Q1 2019$421,00025,3660.01%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders